JUNB and urothelial carcinoma: In UM-UC-3 human urothelial carcinoma cells, FGF2 was found to exhibit anti-proliferative activity by affecting the intracellular transcriptional activity via the modulation of JUNB and FosB proto-oncogene (FOSB) [155].